In recent discussions among top AI researchers, the potential existential threat posed by advanced artificial intelligence has emerged as a significant concern. Leading figures in the field, including Dario Amodei, Sam Altman, and Elon Musk, have expressed the need for a cautious approach to AI development. This dialogue has sparked debates about the implications of unchecked AI advancements, with some experts advocating for stronger regulations and independent monitoring to mitigate risks. A prominent roundtable event, hosted by MIT Technology Review, will delve into these fears and explore actionable solutions for a safer AI future. Participants can register for this crucial conversation scheduled for September 15 at 16:00 BST.
On a more optimistic note, groundbreaking work in genetic research is leading to innovative therapies aimed at reversing age-related vision loss. Geneticist Yuancheng (Ryan) Lu, known for his commitment to combating aging and improving eyesight, has developed a pioneering age-reversal technique that has shown promising results in preclinical trials. His research, which successfully restored vision in blind mice by repairing optic nerves, is now transitioning to human clinical trials. Lu’s efforts not only highlight the potential of genetic therapies in rejuvenation science but also underscore the importance of addressing genetic factors that contribute to conditions like macular degeneration. This exciting advancement could revolutionize how we approach age-related blindness and offer new hope to millions suffering from vision impairment.
Source: The Download: AI’s real extinction threat and age-reversal tech for eyes via MIT Technology Review